P. M. Wilson, P. O. Bohanes, C. J. Rankin, J. K. Benedetti, C. M. Ulrich, S. R. Smalley, K. W. Makar, W. Zhang, T. Winder, Y. Ning, A. Gerger, L. Benhaim, R. El-Khoueiry, M. J. Labonte, C. D. Blanke, H. Lenz.
The final results of the SWOG S9304 phase III intergroup trials pharmacogenetic analysis: Association of polymorphisms with survival and toxicity in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation (RT).
J Clin Oncol 29: 2011 (suppl; abstr 3542)2011; -2011 ASCO Annual Meeting; Jun 3-7, 2011; chicago.
[Poster]